Public Employees Retirement Association of Colorado
RVNC

Public Employees Retirement Association of Colorado’s Revance Therapeutics, Inc. RVNC Stock Holding History

Public Employees Retirement Association of Colorado’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,252
Closed -$46K – 1933
2024
Q4 		$46K Hold
15,252
– – ﹤0.01% 1865
2024
Q3 		$79K Hold
15,252
– – ﹤0.01% 1796
2024
Q2 		$39K Hold
15,252
– – ﹤0.01% 1876
2024
Q1 		$75K Hold
15,252
– – ﹤0.01% 1797
2023
Q4 		$134K Hold
15,252
– – ﹤0.01% 1712
2023
Q3 		$175K Hold
15,252
– – ﹤0.01% 1581
2023
Q2 		$386K Hold
15,252
– – ﹤0.01% 1200
2023
Q1 		$491K Hold
15,252
– – ﹤0.01% 1027
2022
Q4 		$282K Hold
15,252
– – ﹤0.01% 1414
2022
Q3 		$412K Hold
15,252
– – ﹤0.01% 1139
2022
Q2 		$211K Hold
15,252
– – ﹤0.01% 1592
2022
Q1 		$297K Hold
15,252
– – ﹤0.01% 1483
2021
Q4 		$249K Hold
15,252
– – ﹤0.01% 1646
2021
Q3 		$425K Hold
15,252
– – ﹤0.01% 1327
2021
Q2 		$452K Hold
15,252
– – ﹤0.01% 1304
2021
Q1 		$426K Hold
15,252
– – ﹤0.01% 1313
2020
Q4 		$432K Buy
+15,252
New +$395K ﹤0.01% 1213

Other funds holding RVNC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Public Employees Retirement Association of Colorado's RVNC Position: Q1 2025 in Review

Public Employees Retirement Association of Colorado sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 15,252 shares — an estimated $46K sold.

Public Employees Retirement Association of Colorado first reported a position in RVNC in Q4 2020 and held it in 17 quarters. The position peaked at $491K in Q1 2023. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

  • Public Employees Retirement Association of Colorado reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 15,252 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $46K.
  • Public Employees Retirement Association of Colorado first reported a position in Revance Therapeutics, Inc. in Q4 2020 and held it in 17 quarters.
  • Public Employees Retirement Association of Colorado's Revance Therapeutics, Inc. position peaked at $491K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q1 2025, filed 12 May 2025.